Gene Therapy for Rare Disorders conference
Gene Therapy for Rare Disorders is dedicated to overcoming the unique drug development challenges encountered in transforming gene therapy concepts into reality for rare disease patients in need.
As the gene therapy field strives to strike the balance between clinical efficacy and product safety in the context of mounting regulatory scrutiny, Gene Therapy for Rare Disorders 2022 will provide in-depth insights from experts who know how to drive clinical progress, optimize manufacturing, and demonstrate the value of gene therapy products to regulators, payers, and patients.
Across four days, this meeting will unite 500+ leading experts in Boston from innovative biotechs, large pharma, academia, and key service provider companies, delivering actionable insights and valuable networking opportunities to accelerate gene therapy progress.
About the Speaker
Joe DePinto, Chief Commercial Officer
Wednesday, March 9th at 2:30 pm ET Joe DePinto, Chief Commercial Officer, Vineti Delivering Value By Partnering with Providers - Unique insights into challenges faced by Healthcare Providers working with gene therapies - Proactive planning for both current and upcoming phases of gene therapy patient care - Solutions that provide a true partnership with providers and sites for care